Taken together, these results indicate that P-gp activity, as determined by the Calcein assay performed on tumor cells obtained at diagnosis, does not predict therapy response and survival in canine B-cell lymphoma. Here, PGP is linked to B-cell non-Hodgkin lymphoma.